Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymoma
Siri Ippagunta(St. Jude Children's Research Hospital), Kelsey C. Bertrand(University of Toronto), Amir Arabzade(Baylor College of Medicine), Amanda Bland(St. Jude Children's Research Hospital), Martine F. Roussel(St. Jude Children's Research Hospital), Tuyu Zheng(St. Jude Children's Research Hospital), Emma Caesar(St. Jude Children's Research Hospital), Anoop Kavirayani(Vienna Biocenter), Srinidhi Varadharajan(Baylor College of Medicine), Wilda Orisme(St. Jude Children's Research Hospital), Stephen C. Mack(St. Jude Children's Research Hospital), Benjamin Deneen(Baylor College of Medicine), Arzu Onar‐Thomas(St. Jude Children's Research Hospital), David W. Ellison(St. Jude Children's Research Hospital), Erik Emanus(St. Jude Children's Research Hospital), Nicholas Laboe(St. Jude Children's Research Hospital), Hua Sun(St. Jude Children's Research Hospital), Gregory Turner(St. Jude Children's Research Hospital), Richard Kriwacki(St. Jude Children's Research Hospital), Giles Robinson(St. Jude Children's Research Hospital), Burgess Freeman(St. Jude Children's Research Hospital), Maxwell Park(St. Jude Children's Research Hospital), Amelia Hancock(St. Jude Children's Research Hospital), Shondra Pruett-Miller(St. Jude Children's Research Hospital), Melissa Johnson(St. Jude Children's Research Hospital), Alisha Kardian(St. Jude Children's Research Hospital), Anang Shelat(St. Jude Children's Research Hospital), Michael D Taylor(Texas Children's Hospital), Jeffrey Steinberg(St. Jude Children's Research Hospital), Sameer Agnihotri(University of Pittsburgh), Mark Zhai(St. Jude Children's Research Hospital), Thomas E. Merchant(St. Jude Children's Research Hospital), Brittany Rodgers(St. Jude Children's Research Hospital), Jacob Steele(St. Jude Children's Research Hospital)
Cited by 1
Related Papers
Germline Mutations in Predisposition Genes in Pediatric Cancer
|New England Journal of Medicine|2015|1.4k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
|Genes & Development|1998|1.2k
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853